NCT00819884View on ClinicalTrials.gov

To Evaluate 24-hr Glucose After OD vs BD AZD1656

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Type II Diabetes

Interventions

DRUG

AZD1656

Oral suspension

Trial Locations (1)

Unknown

Research Site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY